Erlocure 150 – Erlotinib 150mg Tablet

Erlocure 150 – Erlotinib 150mg Tablet Description:

Geftifine 250 – Gefitinib 250 mg Tablet is a targeted anticancer medicine belonging to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs). It works by blocking the EGFR protein, which plays a key role in the growth and spread of certain cancer cells. By inhibiting EGFR signaling, Erlotinib helps slow or stop cancer cell growth.

It is primarily indicated for patients with EGFR mutation-positive non-small cell lung cancer (NSCLC) and, in selected cases, for pancreatic cancer in combination with gemcitabine.

 Erlocure 150 – Erlotinib 150mg tablet Uses:

Erlocure 150 – Erlotinib 150mg Tablet is primarily used for:

• EGFR mutation-positive Non-Small Cell Lung Cancer (NSCLC)
• Maintenance treatment of advanced or metastatic NSCLC
• Locally advanced or metastatic pancreatic cancer (in combination with gemcitabine)
• Treatment of advanced EGFR-positive lung cancer as prescribed by an oncologist

Side Effects:

 Common Side Effects:

• Skin rash (acne-like rash)
• Diarrhea
• Loss of appetite
• Fatigue
• Nausea
• Mouth sores (stomatitis)
• Dry skin
• Cough

Serious Side Effects :

• Severe lung inflammation (Interstitial Lung Disease)
• Severe diarrhea leading to dehydration
• Liver problems (elevated liver enzymes, jaundice)
• Severe skin reactions with blistering or peeling
• Eye disorders (corneal ulceration, severe eye irritation)
• Gastrointestinal perforation (rare but serious)
• Severe allergic reactions (rash, swelling, difficulty breathing)

Dosage:

The usual recommended dose of Erlocure 150 – Erlotinib 150mg is,

• Recommended dose: 150mg once daily
• Take at least 1 hour before or 2 hours after food (on an empty stomach).
• Swallow the tablet whole with water; do not crush or chew.
• Continue treatment exactly as prescribed by the oncologist.
• Dose adjustments may be required based on side effects, liver function, or interactions with other medicines.

It is important to follow the dosage instructions provided by your healthcare provider or pharmacist when taking Erlotinib. Taking more than the recommended dose of Geftinib can increase the risk of side effects and may not improve the effectiveness of the medication. Take Erlocure 150 – Erlotinib 150mg Tablet in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it.

Important Precautions:

• Smoking can reduce the effectiveness of Erlotinib; patients are advised to avoid smoking during treatment.
• Regular monitoring of liver function and assessment for skin, eye, and lung-related side effects are recommended.
• Avoid taking proton pump inhibitors (PPIs) such as omeprazole or pantoprazole unless specifically advised, as they may reduce Erlotinib absorption.
• Women should avoid becoming pregnant during treatment and for the recommended period after stopping therapy. Breastfeeding is not recommended during treatment.